The Sca-1+ mesenchymal stromal cells modulate macrophage commitment and function

These data demonstrated that Sca-1+MSCs could regulate the commitment and function of macrophages from hematopoietic progenitors, which provided new evidence for elucidating the role of MSC subpopulations in hematopoiesis.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:Mesenchymal stromal cells (MSCs) have been characterized as an important component of the hematopoietic niche that plays a role in regulating hematopoietic stem cell (HSC) quiescence, self-renewal, and lineage commitment.

📊

Temel Bulgular & Veri:The current study compared the contribution of MSCs and Sca-1+MSCs to macrophage commitment and further modulation on the function of macrophages.

💡

Sonuç & Katkı:These data demonstrated that Sca-1+MSCs could regulate the commitment and function of macrophages from hematopoietic progenitors, which provided new evidence for elucidating the role of MSC subpopulations in hematopoiesis.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Abstract

Mesenchymal stromal cells (MSCs) have been characterized as an important component of the hematopoietic niche that plays a role in regulating hematopoietic stem cell (HSC) quiescence, self-renewal, and lineage commitment. Macrophages, one kind of innate immune cells, are mainly developed from HSCs in niche. However, how MSCs and their subpopulations regulate macrophage commitment is still unknown. The current study compared the contribution of MSCs and Sca-1+MSCs to macrophage commitment and further modulation on the function of macrophages. We found that Sca-1+MSCs could promote macrophage commitment through the M-CSFR gene, and Sca-1+MSCs led macrophage polarization towards the M2 phenotype. Further functional studies indicated that Sca-1+MSCs could remarkably promote the phagocytosis capability of macrophages instead of their antigen-presentation ability. These data demonstrated that Sca-1+MSCs could regulate the commitment and function of macrophages from hematopoietic progenitors, which provided new evidence for elucidating the role of MSC subpopulations in hematopoiesis.

🔖

Bu Makaleye Atıf Yap

LI, N., CHEN, Y., HU, X., LIU, Z., CHEN, Y., YIN, D., WANG, Y., AN, N., WEN, F., XIN, J., ZHANG, H., YIN, W. (2022). The Sca-1+ mesenchymal stromal cells modulate macrophage commitment and function. Turkish Journal of Biology, Cilt: 40 - Sayı: 2, 473–483. https://ajindex.com/articles/600367

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P (2013). Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta 1836: 321–335.
Bernardo ME, Fibbe WE (2013). Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13: 392–402.
Chen PM, Yen ML, Liu KJ, Sytwu HK,Yen BL (2011). Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci 18: 49. Cho DI, Kim MR, Jeong HY, Jeong HC, Jeong MH, Yoon SH, Kim YS, Ahn Y (2014). Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med 46: e70. Dayan V, Yannarelli G, Billia F, Filomeno P, Wang XH, Davies JE, Keating A (2011). Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res Cardiol 106: 1299–1310.
Ding L, Saunders TL, Enikolopov G,Morrison SJ (2012). Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 481: 457–462.
Eggenhofer E, Hoogduijn MJ (2012). Mesenchymal stem cell educated macrophages. Transplant Res 1: 12. Espagnolle N, Guilloton F, Deschaseaux F, Gadelorge M, Sensebe L, Bourin P (2014). CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J Cell Mol Med 18: 104–114.
Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD (2007). Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J Immunol 178: 5245–5252.
Francois M, Romieu-Mourez R, Li M, Galipeau J (2012). Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation. Mol Ther 20: 187–195.
Frenette PS, Pinho S, Lucas D, Scheiermann C (2013). Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol 31: 285–316.
Gordon S (2003). Alternative activation of macrophages. Nat Rev Immunol 3: 23–35.
Gordon S, Taylor PR (2005). Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953–964.
Hume DA, MacDonald KP (2012). Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119: 1810–1820.
Kim J, Hematti P (2009). Mesenchymal stem cell-educated macro